biomicsinc.com

What It Is

Biomics Inc.’s TachyNA™ Direct Pass cfDNA Kit is not SaaS or enterprise software, but a circulating cell-free DNA (cfDNA) extraction kit for life science laboratories. The page lists its catalog number as NA11-100 and indicates that shipping has started. It is positioned for rapid isolation of cfDNA from human plasma and serum, and is limited to Research Use Only (RUO).

Core Capabilities

The product uses Biomics’ NA-DP™ (Nucleic Acid Dynamic Pass) technology, emphasizing single-pass dynamic purification without the traditional lengthy bind-wash-elute workflow. Its key specifications include a low input volume of 50–100 µL, a manual workflow of under 10 minutes, a 3–5 minute end-to-end process, suitability for short fragments of 50–150 bp, and claimed efficient recovery of 50–150 bp fragments. Downstream applications include qPCR, dPCR, ddPCR, NGS, methylation analysis, and fragmentomics. In terms of workflow, it supports both manual centrifugation and use with syringe-based POCT, vacuum manifolds, and automation platforms such as Hamilton, Tecan, and Tomtec.

Pricing and Purchasing

The page does not disclose specific pricing, but states that there are currently two SKUs: a 50-test standard kit and a 20-test evaluation pack. Purchasing supports secure checkout and credit card payment; bulk pricing, distributor terms, OEM arrangements, and large-volume projects require contacting sales.

Pros and Cons

Its strengths lie in its clear focus on cfDNA use cases, with particular emphasis on low sample volume, short-fragment retention, and rapid processing, making it attractive for research in MRD, liquid biopsy, NIPT, donor-derived cfDNA, and pathogen cfDNA. Its automation compatibility also makes it suitable for high-throughput laboratories. The limitations are that key comparative data mainly come from the company’s internal head-to-head testing, and full data are available only to qualified customers under NDA. Pricing, company country, after-sales service, and clinical regulatory qualifications are not disclosed. In addition, the product is for research use only and should not be regarded as a clinical diagnostic solution.

Who It’s For and Access in China

It is better suited for research or translational medicine laboratories in oncology, maternal and child health, transplantation, infectious disease, and multi-omics, especially for validating short-fragment cfDNA recovery and low-input sample workflows. The main text does not provide information on access from China, so its status is unknown.